Clinical Trial Update: Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update investigates the safety and efficacy of intravenously administered autologous adipose-derived mesenchymal stem cells (ADMSc) for idio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (ADMSc) (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Kasiak Research Pvt. Ltd. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1, Phase 2 | Status: UNKNOWN